A Phase 2 Randomized Controlled Trial Repurposing Ambroxol as a Disease Modifying Treatment for Parkinson's disease Dementia.

被引:0
|
作者
Pasternak, S. H.
Silviera, C.
Coleman, K.
Finger, E.
Wells, J.
Borrie, M.
Morrow, S.
Zou, G.
Bartha, R.
Macdonald, P.
Jenkins, M. E.
Jog, M.
Tirona, R.
Rupar, C. A.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
429
引用
收藏
页码:S189 / S190
页数:2
相关论文
共 50 条
  • [31] Pilot randomized controlled trial of telemedicine for individuals with Parkinson's disease
    Dorsey, R.
    Deuel, L.
    Appler, A.
    Eason, S.
    George, B.
    Joseph, A.
    Miller, D.
    Polanowicz, J.
    Reminick, J.
    Smith, S.
    Viti, L.
    Voss, T.
    Biglan, K.
    MOVEMENT DISORDERS, 2009, 24 : S261 - S261
  • [32] Rehabilitating Cough Dysfunction in Parkinson's Disease: A Randomized Controlled Trial
    Troche, Michelle S.
    Curtis, James A.
    Sevitz, Jordanna S.
    Dakin, Avery E.
    Perry, Sarah E.
    Borders, James C.
    Grande, Alessandro A.
    Mou, Yuhan
    Vanegas-Arroyave, Nora
    Hegland, Karen W.
    MOVEMENT DISORDERS, 2023, 38 (02) : 201 - 211
  • [33] Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial
    van der Marck, Marjolein A.
    Bloem, Bastiaan R.
    Borm, George F.
    Overeem, Sebastiaan
    Munneke, Marten
    Guttman, Mark
    MOVEMENT DISORDERS, 2013, 28 (05) : 605 - 611
  • [34] A Randomized Controlled Trial to Reduce Falls in People With Parkinson's Disease
    Morris, Meg E.
    Menz, Hylton B.
    McGinley, Jennifer L.
    Watts, Jennifer J.
    Huxham, Frances E.
    Murphy, Anna T.
    Danoudis, Mary E.
    Iansek, Robert
    NEUROREHABILITATION AND NEURAL REPAIR, 2015, 29 (08) : 777 - 785
  • [35] Randomised controlled trial of memantine in dementia associated with Parkinson's disease (PDD)
    Leroi, Iracema
    Overshott, Ross
    Daniel, Emily
    Byrne, E. Jane
    Burns, Alistair
    NEUROLOGY, 2008, 70 (11) : A327 - A327
  • [36] Mesdopetam for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease: A Randomized Phase 2b Trial
    Antonini, Angelo
    O'Suilleabhain, Padraig
    Stocchi, Fabricio
    Landstrom, Johanna
    Waters, Susanna
    Sonesson, Clas
    Tedroff, Joakim
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2025,
  • [37] Expectations of Benefit in a Trial of a Candidate Disease-Modifying Treatment for Parkinson Disease
    Mestre, Tiago A.
    Macklin, Eric A.
    Ascherio, Alberto
    Ferreira, Joaquim J.
    Lang, Anthony E.
    Schwarzschild, Michael A.
    MOVEMENT DISORDERS, 2021, 36 (08) : 1964 - 1967
  • [38] Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial
    Holloway, R
    Shoulson, I
    Kieburtz, K
    McDermott, M
    Tariot, P
    Kamp, C
    Day, D
    Shinaman, A
    Fahn, S
    Lang, A
    Marek, K
    Seibyl, J
    Weiner, W
    Welsh, M
    Pahwa, R
    Coe, S
    Barclay, L
    Sutherland, L
    Hildebrand, K
    Hubble, J
    Weeks, C
    LeWitt, P
    Miyasaki, J
    Duff, J
    Sime, E
    Suchowersky, O
    Stacy, M
    Kurth, M
    Brewer, M
    Harrigan, M
    Russell, DS
    Fussell, B
    Ford, B
    Dillon, S
    Hammerstad, J
    Stone, C
    Riley, D
    Rainey, P
    Standaert, D
    Tennis, M
    Wooten, F
    Rost-Ruffner, E
    Factor, S
    Brown, D
    Jankovic, J
    Atassi, F
    Kurlan, R
    Gardiner, I
    Panisset, M
    Amyot, D
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (15): : 1931 - 1938
  • [39] Montelukast as Disease Modifying Treatment for Parkinson's Disease: A Pilot Study
    Wallin, J.
    Svenningsson, P.
    MOVEMENT DISORDERS, 2023, 38 : S58 - S59
  • [40] A randomized, controlled trial of linopirdine in the treatment of Alzheimer's disease
    Rockwood, K
    Beattie, BL
    Eastwood, MR
    Feldman, H
    Mohr, E
    PrysePhillips, W
    Gauthier, S
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1997, 24 (02) : 140 - 145